Aflac's annual Atlanta Braves night is a tradition where Aflac Cancer and Blood Disorders Center patients, families and staff come together for a welcome break and to cheer on the World Series Champions. After a brief hiatus due to the pandemic, Aflac was thrilled to host the 25th annual Braves Night that included face painting, pingpong, cornhole, coloring and more. Enjoy a recap of this special night full of baseball, BLOOPER and some incredibly inspiring kids.

Aflac Cancer and Blood Disorders Center

Since 1995, the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta has become nationally renowned as one of the leading childhood cancer, hematology, and blood and marrow transplant programs in the U.S. With innovative research programs and cutting-edge treatment options, the five-year survival rate for childhood cancer has improved dramatically, from 20% in 1965 to greater than 80% today. This worthwhile cause is very near and dear to the heart of the Aflac family, including the Aflac Foundation, Inc., our executives, employees and the field force, whose generous contributions help to provide a steady flow of funding for research. In total, Aflac’s contributions to the Aflac Cancer Center have exceeded the $160 million mark as of April 2022. This generosity has greatly contributed to the Aflac Cancer Center’s success and distinction in research, which has earned the Aflac Cancer Center recognition as one of the top pediatric cancer programs in the country by U.S. News and World Report. Aflac’s commitment is not only positively impacting kids with childhood cancer, but also those with rare blood disorders, including sickle cell disease – a disease that is not widely known or understood.

The inspiration for Aflac’s efforts to help address challenges brought on by sickle cell disease, in relation to larger disparities in pediatric health care, are largely centered on the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta: The Aflac Cancer Center is the most prolific provider of sickle cell disease care in the U.S., caring for nearly 2,000 pediatric patients each year and regularly performing blood and marrow transplants. In 2020, it was rated No. 1 in the nation for total sickle cell disease discharges in 2020 with 2,000-plus total patient visits, according to the Public Health Information System Data.